The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Tanaka, Hirotaka ^a   Shimazawa, Masamitsu ^a   Kimura, Masataka ^a   Takata, Masafumi ^a   Tsuruma, Kazuhiro ^a   Yamada, Mitsunori ^b   Takahashi, Hitoshi ^c   Hozumi, Isao ^a   Niwa, Jun Ichi ^d   Iguchi, Yohei ^e   Nikawa, Takeshi ^f   Sobue, Gen ^e   Inuzuka, Takashi ^g   Hara, Hideaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b National Saigata Medical Center   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

^d AICHI MEDICAL UNIVERSITY   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF TOKUSHIMA   (Japan)

^g GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EYE PROTEIN; GPNMB PROTEIN, MOUSE; MEMBRANE PROTEIN; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL DEATH; DISEASE MODEL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MORTALITY; MOTONEURON; MOUSE; MUTATION; PROTEIN BINDING; RNA INTERFERENCE; SPINAL CORD; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL DEATH; DISEASE MODELS, ANIMAL; EYE PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MOTOR NEURONS; MUTATION; PROTEIN BINDING; RNA INTERFERENCE; SPINAL CORD; SUPEROXIDE DISMUTASE;

EID: 84866097059     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00573     Document Type: Article

References (50)

1. Wijesekera, L. C. & Leigh, P. N. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 4, 3 (2009).
2. Dion, P. A., Daoud, H. & Rouleau, G. A. Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat Rev Genet. 10, 769-782 (2009).
3. Vande Velde, C., Dion, P. A. & Rouleau, G. A. Amyotrophic lateral sclerosis: new genes, new models, and new mechanisms. F1000 Biol Rep. 3, 18 (2011).
4. Jackson, M., Ganel, R. & Rothstein, J. D. Models of amyotrophic lateral sclerosis. Curr Protoc Neurosci. Chapter 9, Unit 9 13 (2002).
5. Ferraiuolo, L. et al. Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. J Neurosci. 27, 9201-9219 (2007). (Pubitemid 47312070)
6. Olsen, M. K. et al. Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann Neurol. 50, 730-740 (2001). (Pubitemid 33116132)
7. Yoshihara, T. et al. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem. 80, 158-167 (2002). (Pubitemid 34614588)
8. Lobsiger, C. S., Boillee, S. & Cleveland, D. W. Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons. Proc Natl Acad Sci U S A. 104, 7319-7326 (2007). (Pubitemid 47185903)
9. Vargas, M. R., Pehar, M., Diaz-Amarilla, P. J., Beckman, J. S. & Barbeito, L. Transcriptional profile of primary astrocytes expressing ALS-linked mutant SOD1. J Neurosci Res. 86, 3515-3525 (2008).
10. Dangond, F. et al. Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol Genomics. 16, 229-239 (2004). (Pubitemid 38420040)
11. Ishigaki, S. et al. Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords-screening by molecular indexing and subsequent cDNA microarray analysis. FEBS Lett. 531, 354-358 (2002). (Pubitemid 35341223)
12. Jiang, Y. M. et al. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann Neurol. 57, 236-251 (2005).
13. Malaspina, A., Kaushik, N. & de Belleroche, J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem. 77, 132-145 (2001). (Pubitemid 32245087)
14. Offen, D. et al. Spinal cord mRNA profile in patients with ALS: comparison with transgenic mice expressing the human SOD-1 mutant. J Mol Neurosci. 38, 85-93 (2009).
15. Wang, X. S., Simmons, Z., Liu, W., Boyer, P. J. & Connor, J. R. Differential expression of genes in amyotrophic lateral sclerosis revealed by profiling the post mortem cortex. Amyotroph Lateral Scler. 7, 201-210 (2006).
16. Kudo, L. C. et al. Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis. Hum Mol Genet. 19, 3233-3253 (2010).
17. Weterman, M. A. et al. nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts. Int J Cancer. 60, 73-81 (1995).
18. Ripoll, V. M. et al. Microphthalmia transcription factor regulates the expression of the novel osteoclast factor GPNMB. Gene. 413, 32-41 (2008).
19. Abdelmagid, S. M. et al. Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function. Exp Cell Res. 314, 2334-2351 (2008).
20. Chung, J. S., Dougherty, I., Cruz, P. D., Jr. & Ariizumi, K. Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation. J Immunol. 179, 5778-5784 (2007).
21. Ogawa, T. et al. Osteoactivin upregulates expression of MMP-3 and MMP-9 in fibroblasts infiltrated into denervated skeletal muscle in mice. Am J Physiol Cell Physiol. 289, C697-707 (2005). (Pubitemid 41192679)
22. Williams, M. D. et al. GPNMB expression in uveal melanoma: a potential for targeted therapy. Melanoma Res. 20, 184-190 (2010).
23. Kuan, C. T. et al. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme. Clin Cancer Res. 12, 1970-1982 (2006).
24. Rich, J. N. et al. Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J Biol Chem. 278, 15951-15957 (2003). (Pubitemid 36799713)
25. Rose, A. A. et al. Osteoactivin promotes breast cancer metastasis to bone. Mol Cancer Res. 5, 1001-1014 (2007). (Pubitemid 350070756)
26. Onaga, M. et al. Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, L-amino acid-defined diet, accelerates motility of hepatoma cells. J Hepatol. 39, 779-785 (2003). (Pubitemid 37372188)
27. Tse, K. F. et al. CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma. Clin Cancer Res. 12, 1373-1382 (2006). (Pubitemid 43342531)
28. Anderson, M. G. et al. Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat Genet. 30, 81-85 (2002).
29. Furochi, H. et al. Osteoactivin fragments produced by ectodomain shedding induce MMP-3 expression via ERK pathway in mouse NIH-3T3 fibroblasts. FEBS Lett. 581, 5743-5750 (2007). (Pubitemid 350235424)
30. Rose, A. A. et al. ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties. PLoS One. 5, e12093 (2010).
31. Liu, Y., Hao, W., Dawson, A., Liu, S. & Fassbender, K. Expression of amyotrophic lateral sclerosis-linked SOD1 mutant increases the neurotoxic potential of microglia via TLR2. J Biol Chem. 284, 3691-3699 (2009).
32. Shinder, G. A., Lacourse, M. C., Minotti, S. & Durham, H. D. Mutant Cu/Znsuperoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis. J Biol Chem. 276, 12791-12796 (2001).
33. Wang, J. et al. Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum Mol Genet. 12, 2753-2764 (2003). (Pubitemid 37407112)
34. Urushitani, M. et al. CHIP promotes proteasomal degradation of familial ALSlinked mutant SOD1 by ubiquitinating Hsp/Hsc70. J Neurochem. 90, 231-244 (2004). (Pubitemid 38879177)
35. Kunst, C. B., Mezey, E., Brownstein, M. J. & Patterson, D. Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions. Nat Genet. 15, 91-94 (1997). (Pubitemid 27014957)
36. Ciechanover, A. & Brundin, P. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron. 40, 427-446 (2003). (Pubitemid 37244106)
37. Vargas, M. R., Pehar, M., Cassina, P., Beckman, J. S. & Barbeito, L. Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75NTRdependent motor neuron apoptosis. J Neurochem. 97, 687-696 (2006).
38. Di Giorgio, F. P., Carrasco, M. A., Siao, M. C., Maniatis, T. & Eggan, K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci. 10, 608-614 (2007). (Pubitemid 46652442)
39. Nagai, M. et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci. 10, 615-622 (2007). (Pubitemid 46652435)
40. Adema, G. J., Bakker, A. B., de Boer, A. J., Hohenstein, P.& Figdor, C. G. pMel17 is recognised by monoclonal antibodies NKI-beteb, HMB-45 and HMB-50 and by anti-melanoma CTL. Br J Cancer. 73, 1044-1048 (1996). (Pubitemid 26131222)
41. Berson, J. F., Harper, D. C., Tenza, D., Raposo, G. & Marks, M. S. Pmel17 initiates premelanosome morphogenesis within multivesicular bodies. Mol Biol Cell. 12, 3451-3464 (2001). (Pubitemid 33108478)
42. Fowler, D. M. et al. Functional amyloid formation within mammalian tissue. PLoS Biol. 4, e6 (2006).
43. Rose, A. A. et al. Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer. Clin Cancer Res. 16, 2147-2156 (2010).
44. Lasiene, J. & Yamanaka, K. Glial cells in amyotrophic lateral sclerosis. Neurol Res Int. 2011, 718987 (2011).
45. Yamanaka, K. et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci. 11, 251-253 (2008). (Pubitemid 351311795)
46. Ilieva, H., Polymenidou, M. & Cleveland, D. W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol. 187, 761-772 (2009).
47. Ekestern, E. Neurotrophic factors and amyotrophic lateral sclerosis. Neurodegener Dis. 1, 88-100 (2004). (Pubitemid 39369422)
48. Dewil, M. et al. Vascular endothelial growth factor counteracts the loss of phospho-Akt preceding motor neurone degeneration in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 33, 499-509 (2007). (Pubitemid 47390084)
49. Tanaka, H. et al. Apoptosis-inducing factor and cyclophilin a cotranslocate to the motor neuronal nuclei in amyotrophic lateral sclerosis model mice. CNS Neurosci Ther. 17, 294-304 (2011).
50. Niwa, J. et al. Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1- mediated neurotoxicity. J Biol Chem. 277, 36793-36798 (2002).